Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice

British Journal of Pharmacology

Volumn 140, Issue 5, 2003, Pages 831-838

  Salzmann, Julie ^a   Marie Claire, Cynthia ^a   Le Guen, Stéphanie ^a   Roques, Bernard P ^a   Noble, Florence ^a  

^a Laboratoire de Pharmacochimie   (France)

Author keywords

ERK; Immediate early genes; Locomotor activity; MDMA; Place preference

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN C FOS; RAS PROTEIN; SL 327; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR EGR 3; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; GENETIC TRANSCRIPTION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; LOCOMOTION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUTAMEN; REINFORCEMENT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CONDITIONING (PSYCHOLOGY); ENZYME ACTIVATION; GENES, IMMEDIATE-EARLY; LOCOMOTION; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE;

EID: 0344873167     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705506     Document Type: Article

References (43)

1. ALI, S.F., THIRIET, N. & ZWILLER, J. (1999). Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain. Mol. Brain Res., 74, 237-241.
2. ATKINS, C.M., SELCHER, J.C., PETRAITIS, J.J., TRZASKOS, J.M. & SWEATT, J.D. (1998). The MAPK cascade is required for mammalian associative learning. Nat. Neurosci., 1, 602-609.
3. BATTAGLIA, G., BROOKS, B.P., KULSAKDINUN, C. & DE SOUZA, E.B. (1988). Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Eur. J. Pharmacol., 149, 159-163.
4. BERKELEY, J.L., GOMEZA, J., WESS, J., HAMILTON, S.E., NATHANSON, N.M. & LEVEY, A.I. (2001). M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices. Mol. Cell Neurosci., 18, 512-524.
5. BILSKY, E.J. & REID, L.D. (1991). MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol. Biochem. Behav., 39, 509-512.
6. BLAKE, J.A., RICHARDSON, J.E., BULT, C.J., KADIN, J.A. & EPRIG, J.T. (2003). MGD: the Mouse Genome Database. Nucleic Acids Res., 31, 193-195.
7. DAVIS, S., VANHOUTTE, P., PAGES, C., CABOCHE, J. & LAROCHE, S. (2000). The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J. Neurosci., 20, 4563-4572.
8. DI CHIARA, G. (1995). The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend., 38, 95-137.
9. DRAGUNOW, M., LOGAN, B. & LAVERTY, R. (1991). 3,4- Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801. Eur. J. Pharmacol., 206, 255-258.
10. ERDTMANN-VOURLIOTIS, M., MAYER, P., RIECHERT, U. & HOLLT, V. (1999). Acute injection of drugs with low addictive potential (Δ(9)- tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting drugs (cocaine and morphine). Mol. Brain Res., 71, 313-324.
11. ERDTMANN-VOURLIOTIS, M., MAYER, P., RIECHERT, U. & HOLLT, V. (2000). Prior experience of morphine application alters the c-fos response to MDMA ('ecstasy') and cocaine in the rat striatum. Mol. Brain Res., 77, 55-64.
12. HERDEGEN, T. & LEAH, J.D. (1998). Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev., 28, 370-490.
13. HERDEGEN, T., KOVARY, K., BUHL, A., BRAVO, R., ZIMMERMANN, M. & GASS, P. (1995). Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 in the adult rat brain. J. Comp. Neurol., 354, 39-56.
14. JOUVERT, P., DIETRICH, J.B., AUNIS, D. & ZWILLER, J. (2002). Differential rat brain expression of EGR proteins and of the transcriptional corepressor NAB in response to acute or chronic cocaine administration. Neuromol. Med., 1, 137-151.
15. KANKAANPAA, A., MERIRINNE, E., LILLSUNDE, P. & SEPPALA, T. (1998). The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens. Pharmacol. Biochem. Behav., 59, 1003-1009.
16. KEHNE, J.H., KETTELER, H.J., MCCLOSKEY, T.C., SULLIVAN, C.K., DUDLEY, M.W. & SCHMIDT, C.J. (1996). Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology, 15, 116-124.
17. KOOB, G.F. (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci., 13, 177-184.
18. LOVENBERG, T.W., NICHOLS, D.E., NESTLER, E.J., ROTH, R.H. & MAILMAN, R.B. (1991). Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors. Brain Res., 556, 101-107.
19. LOWES, V.L., IP, N.Y. & WONG, Y.H. (2002). Integration of signals from receptor tyrosine kinases and γ protein-coupled receptors. Neurosignals, 11, 5-19.
20. NAKAO, S., MIYAMOTO, E., MASUZAWA, M., KAMBARA, T. & SHINGU, K. (2002). Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors. Brain Res., 926, 191-196.
21. NARITA, M., MAKIMURA, M., FENG, Y., HOSKINS, B. & HO, I.K. (1994). Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res., 650, 175-179.
22. NESTLER, E.J. (2001). Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci., 2, 119-128.
23. O'DONOVAN, K.J., TOURTELLOTTE, W.G., MILLBRANDT, J. & BARABAN, J.M. (1999). The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci., 22, 167-173.
24. ORTIZ, J., FITZGERALD, L.W., CHARLTON, M., LANE, S., TREVISAN, L., GUITART, X., SHOEMAKER, W., DUMAN, R.S. & NESTLER, E.J. (1995). Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse, 21, 289-298.
25. PULLARKAT, S.R., MYSELS, D.J., TAN, M. & COWEN, D.S. (1998). Coupling of serotonin 5-HT1B receptors to activation of mitogen-activated protein kinase (ERK-2) and p70 S6 kinase signaling systems. J. Neurochem., 71, 1059-1067.
26. SCEARCE-LEVIE, K., VISWANATHAN, S.S. & HEN, R. (1999). Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor. Psychopharmacology (Berl), 141, 154-161.
27. SCHOFFELMEER, A.N., VOORN, P., JONKER, A.J., WARDEH, G., NESTBY, P., VANDERSCHUREN, L.J., DE VRIES, T.J., MULDER, A.H. & TJON, G.H. (1996). Morphine-induced increase in D1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization. Neurochem. Res., 21, 1417-1423.
28. SEGER, R. & KREBS, E.G. (1995). The MAPK signaling cascade. FASEB J., 9, 726-735.
29. SELCHER, J.C., ATKINS, C.M., TRZASKOS, J.M., PAYLOR, R. & SWEATT, J.D. (1999). A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem., 6, 478-490.
30. SHIRAYAMA, Y., HASHIMOTO, K., IYO, M., WATANABE, K., HIGUCHI, T. & MINABE, Y. (2000). 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation. Eur. J. Pharmacol., 402, 215-222.
31. STEPHENSON, C.P., HUNT, G.E., TOPPLE, A.N. & MCGREGOR, I.S. (1999). The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"- induced c-fos expression in rat brain. Neuroscience, 92, 1011-1023.
32. SWEATT, J.D. (2001). The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem., 16, 1-10.
33. TERWILLIGER, R.Z., BEITNER-JOHNSON, D., SEVARINO, K.A., CRAIN, S.M. & NESTLER, E.J. (1991). A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res., 548, 100-110.
34. TETER, C.J. & GUTHRIE, S.K. (2001). A comprehensive review of MDMA and GHB: two common club drugs. Pharmacotherapy, 21, 1486-1513.
35. THIRIET, N., ZWILLER, J. & ALI, S.F. (2001). Induction of the immediate early genes egr-1 and c-fos by methamphetamine in mouse brain. Brain Res., 919, 31-40.
36. UNGLESS, M.A., WHISTLER, J.L., MALENKA, R.C. & BONCI, A. (2001). Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature, 411, 583-587.
37. UNTERWALD, E.M., FILLMORE, J. & KREEK, M.J. (1996). Chronic repeated cocaine administration increases dopamine D1 receptor-mediated signal transduction. Eur. J. Pharmacol., 318, 31-35.
38. VALJENT, E., CORVOL, J.C., PAGES, C., BESSON, M.J., MALDONADO, R. & CABOCHE, J. (2000). Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci., 20, 8701-8709.
39. VALJENT, E., PAGES, C., ROGARD, M., BESSON, M.J., MALDONADO, R. & CABOCHE, J. (2001). Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission. Eur. J. Neurosci., 14, 342-352.
40. VALVERDE, O., NOBLE, F., BESLOT, F., DAUGE, V., FOURNIE-ZALUSKI, M.C. & ROQUES, B.P. (2001). Δ9-tetra-hydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur. J. Neurosci., 13, 1816-1824.
41. WATTS, S.W., YANG, P., BANES, A.K. & BAEZ, M. (2001). Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. J. Cardiovasc. Pharmacol., 38, 539-551.
42. WHITE, S.R., OBRADOVIC, T., IMEL, K.M. & WHEATON, M.J. (1996). The effects of methylenedioxymethamphetamine (MDMA. "Ecstasy") on monoaminergic neurotransmission in the central nervous system. Prog. Neurobiol., 49, 455-479.
43. WILLIAMS, J.M., BECKMANN, A.M., MASON-PARKER, S.E., ABRAHAM, W.C., WILCE, P.A. & TATE, W.P. (2000). Sequential increase in Egr-1 and AP-I DNA binding activity in the dentate gyms following the induction of long-tenn potentiation. Mol. Brain Res., 11, 258-266.